These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 17015227)

  • 1. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
    Hauser SL; Oksenberg JR
    Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
    Inglese M; Benedetti B; Filippi M
    J Neurol Sci; 2005 Jun; 233(1-2):15-9. PubMed ID: 15949493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuronal injury in multiple sclerosis].
    Correale J; Meli F; Ysrraelit C
    Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
    Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
    Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: is there neurodegeneration independent from inflammation?
    Lassmann H
    J Neurol Sci; 2007 Aug; 259(1-2):3-6. PubMed ID: 17367814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
    Aktas O; Waiczies S; Zipp F
    J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A; Toledo EG; Alexander JS; Kelley RE
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
    Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
    Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of neurodegeneration in multiple sclerosis.
    Lassmann H; van Horssen J
    FEBS Lett; 2011 Dec; 585(23):3715-23. PubMed ID: 21854776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages and neurodegeneration.
    Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
    Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: a battle between destruction and repair.
    McQualter JL; Bernard CC
    J Neurochem; 2007 Jan; 100(2):295-306. PubMed ID: 17101032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration and -protection in autoimmune CNS inflammation.
    Diem R; Sättler MB; Bähr M
    J Neuroimmunol; 2007 Mar; 184(1-2):27-36. PubMed ID: 17188756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A critical review of the current pathogenesis of multiple sclerosis and possible future trends].
    Casanova B; Burgal M; Coret F
    Rev Neurol; 1999 May 1-15; 28(9):909-15. PubMed ID: 10390758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
    Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
    Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S; Azari MF; Ozturk E; Papadopoulos R; Bernard CC
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):323-34. PubMed ID: 20448478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.